Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| 3billion | RCV001283771 | SCV005905054 | pathogenic | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | 2023-11-22 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.002%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000992974 /PMID: 10545950). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
| Biochemical Molecular Genetic Laboratory, |
RCV001283771 | SCV001469143 | pathogenic | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | 2020-09-10 | no assertion criteria provided | clinical testing | |
| OMIM | RCV001283771 | SCV000026188 | pathogenic | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | 1999-11-01 | no assertion criteria provided | literature only |